Jim Cullen recent buys & sells (2022 Q1)
Cullen Value Fund
Cullen Value Fund Portfolio Changes
Purchase & sale details
- Portfolio value:
- $27.34M (-$268K)
- Previous value:
- $27.60M
- # of changes:
- 10
- New positions:
- 3
- Reported for:
- 31 Mar 2022 (Q1)
- Latest filing date:
- 31 May 2022
Cullen Value Fund has disclosed a total of 10 changes to the portfolio in the (2022 Q1) SEC report(s): increased the number of shares of 4, bought 3 totally new, decreased the number of shares of 1 and completely sold out 2 position(s).
What stocks did Jim Cullen buy in 2022 Q1?
During 2022 Q1 Jim Cullen has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (AXP) American Express Company (added shares +11.70%), (CI) Cigna Corp (new buy), (UL) Unilever PLC ADR (added shares +22.52%), (VZ) Verizon Communications Inc (new buy) and (DIS) Walt Disney Company (added shares +5.61%).
In the 2022 Q1 report(s) no changes have been made to any of these investments.
10 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Verizon Communications Inc
|
new
|
+10,786
|
10,786
|
+2.01%
|
$50.94
|
-15.22%($43.18)
|
2.01%
|
2022 Q1
|
~0.25 years
|
|
|
|
Applied Materials Inc
|
new
|
+3,780
|
3,780
|
+1.82%
|
$131.80
|
+213.63%($413.36)
|
1.82%
|
2022 Q1
|
~0.25 years
|
|
|
|
Cigna Corp
|
new
|
+2,364
|
2,364
|
+2.07%
|
$239.61
|
+23.65%($296.27)
|
2.07%
|
2022 Q1
|
~0.25 years
|
|
|
|
Canadian National Railway Company
|
+47.13%
|
+1,209
|
3,774
|
+0.59%
|
$134.14
|
-6.83%($124.98)
|
1.85%
|
2021 Q3
|
~0.75 years
|
|
|
|
Unilever PLC ADR
|
+22.52%
|
+2,278
|
12,393
|
+0.38%
|
$45.57
|
+40.41%($63.99)
|
2.07%
|
2020 Q4
|
~1.50 years
|
|
|
|
American Express Company
|
+11.70%
|
+386
|
3,686
|
+0.26%
|
$187.00
|
+69.28%($316.56)
|
2.52%
|
2021 Q3
|
~0.75 years
|
|
|
|
Walt Disney Company
|
+5.61%
|
+212
|
3,992
|
+0.11%
|
$137.16
|
-20.27%($109.36)
|
2.00%
|
2019 Q3
|
~2.75 years
|
|
|
|
Thermo Fisher Scientific Inc
|
-64.67%
|
-1,155
|
631
|
-2.47%
|
$590.65
|
+19.14%($703.68)
|
1.36%
|
2019 Q3
|
~2.75 years
|
|
|
|
Microsoft Corp
|
-100%
|
-1,085
|
0
|
-1.32%
|
$336.32
|
+56.79%($527.32)
|
0.00%
|
2019 Q3
|
~2.50 years
|
|
|
|
Novartis AG ADR
|
-100%
|
-8,130
|
0
|
-2.58%
|
$87.47
|
+78.52%($156.15)
|
0.00%
|
2019 Q3
|
~2.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".